vs

Side-by-side financial comparison of TriSalus Life Sciences, Inc. (TLSI) and Western New England Bancorp, Inc. (WNEB). Click either name above to swap in a different company.

Western New England Bancorp, Inc. is the larger business by last-quarter revenue ($22.0M vs $13.2M, roughly 1.7× TriSalus Life Sciences, Inc.). Western New England Bancorp, Inc. runs the higher net margin — 23.7% vs -73.9%, a 97.5% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 18.8%). Western New England Bancorp, Inc. produced more free cash flow last quarter ($17.1M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 10.5%).

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

The Bank of New England Corporation refers to a current online real estate bank based in New Hampshire and former regional banking institution based in Boston, Massachusetts, which was seized by the Federal Deposit Insurance Corporation (FDIC) in 1991 as a result of heavy losses in its loan portfolio and was placed into Chapter 7 liquidation. At the time, it was the 33rd largest bank in the United States, and its federal seizure bailout was the second-largest on record. At its peak, it had be...

TLSI vs WNEB — Head-to-Head

Bigger by revenue
WNEB
WNEB
1.7× larger
WNEB
$22.0M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+41.1% gap
TLSI
59.8%
18.8%
WNEB
Higher net margin
WNEB
WNEB
97.5% more per $
WNEB
23.7%
-73.9%
TLSI
More free cash flow
WNEB
WNEB
$19.7M more FCF
WNEB
$17.1M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
10.5%
WNEB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TLSI
TLSI
WNEB
WNEB
Revenue
$13.2M
$22.0M
Net Profit
$-9.8M
$5.2M
Gross Margin
86.7%
Operating Margin
-24.8%
30.1%
Net Margin
-73.9%
23.7%
Revenue YoY
59.8%
18.8%
Net Profit YoY
3.5%
58.4%
EPS (diluted)
$-0.22
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TLSI
TLSI
WNEB
WNEB
Q4 25
$13.2M
$22.0M
Q3 25
$11.6M
$21.3M
Q2 25
$11.2M
$21.1M
Q1 25
$9.2M
$18.3M
Q4 24
$8.3M
$18.5M
Q3 24
$7.3M
$17.9M
Q2 24
$7.4M
$18.3M
Q1 24
$6.5M
$18.0M
Net Profit
TLSI
TLSI
WNEB
WNEB
Q4 25
$-9.8M
$5.2M
Q3 25
$-10.8M
$3.2M
Q2 25
$-8.3M
$4.6M
Q1 25
$-10.4M
$2.3M
Q4 24
$-10.1M
$3.3M
Q3 24
$-2.4M
$1.9M
Q2 24
$-4.3M
$3.5M
Q1 24
$-13.2M
$3.0M
Gross Margin
TLSI
TLSI
WNEB
WNEB
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
TLSI
TLSI
WNEB
WNEB
Q4 25
-24.8%
30.1%
Q3 25
-77.9%
19.7%
Q2 25
-65.4%
28.6%
Q1 25
-79.9%
16.2%
Q4 24
-91.8%
23.5%
Q3 24
-118.9%
14.1%
Q2 24
-111.0%
23.4%
Q1 24
-180.8%
21.0%
Net Margin
TLSI
TLSI
WNEB
WNEB
Q4 25
-73.9%
23.7%
Q3 25
-93.5%
14.9%
Q2 25
-73.9%
21.8%
Q1 25
-113.2%
12.6%
Q4 24
-122.4%
17.7%
Q3 24
-32.6%
10.7%
Q2 24
-58.8%
19.2%
Q1 24
-204.5%
16.4%
EPS (diluted)
TLSI
TLSI
WNEB
WNEB
Q4 25
$-0.22
$0.25
Q3 25
$-0.96
$0.16
Q2 25
$-0.27
$0.23
Q1 25
$-0.39
$0.11
Q4 24
$-0.38
$0.16
Q3 24
$-0.12
$0.09
Q2 24
$-0.21
$0.17
Q1 24
$-0.60
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TLSI
TLSI
WNEB
WNEB
Cash + ST InvestmentsLiquidity on hand
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-33.9M
$247.6M
Total Assets
$35.3M
$2.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TLSI
TLSI
WNEB
WNEB
Q4 25
$20.4M
Q3 25
$22.7M
Q2 25
$26.5M
Q1 25
$13.0M
Q4 24
$8.5M
Q3 24
$11.3M
Q2 24
$16.5M
Q1 24
$4.0M
Stockholders' Equity
TLSI
TLSI
WNEB
WNEB
Q4 25
$-33.9M
$247.6M
Q3 25
$-26.7M
$243.6M
Q2 25
$-19.4M
$239.4M
Q1 25
$-34.4M
$237.7M
Q4 24
$-25.9M
$235.9M
Q3 24
$-20.4M
$240.7M
Q2 24
$-25.3M
$236.5M
Q1 24
$-36.0M
$235.8M
Total Assets
TLSI
TLSI
WNEB
WNEB
Q4 25
$35.3M
$2.7B
Q3 25
$36.5M
$2.7B
Q2 25
$41.3M
$2.7B
Q1 25
$28.6M
$2.7B
Q4 24
$24.0M
$2.7B
Q3 24
$27.5M
$2.6B
Q2 24
$32.4M
$2.6B
Q1 24
$17.9M
$2.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TLSI
TLSI
WNEB
WNEB
Operating Cash FlowLast quarter
$-2.5M
$18.2M
Free Cash FlowOCF − Capex
$-2.5M
$17.1M
FCF MarginFCF / Revenue
-19.1%
77.9%
Capex IntensityCapex / Revenue
0.3%
4.9%
Cash ConversionOCF / Net Profit
3.50×
TTM Free Cash FlowTrailing 4 quarters
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TLSI
TLSI
WNEB
WNEB
Q4 25
$-2.5M
$18.2M
Q3 25
$-3.7M
$5.6M
Q2 25
$-7.3M
$6.8M
Q1 25
$-4.5M
$-1.2M
Q4 24
$-5.7M
$12.2M
Q3 24
$-10.8M
$3.0M
Q2 24
$-13.4M
$2.0M
Q1 24
$-10.9M
$1.2M
Free Cash Flow
TLSI
TLSI
WNEB
WNEB
Q4 25
$-2.5M
$17.1M
Q3 25
$-3.9M
Q2 25
$-7.4M
Q1 25
$-5.3M
Q4 24
$-5.8M
$11.0M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
TLSI
TLSI
WNEB
WNEB
Q4 25
-19.1%
77.9%
Q3 25
-33.9%
Q2 25
-66.1%
Q1 25
-57.3%
Q4 24
-69.7%
59.2%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
TLSI
TLSI
WNEB
WNEB
Q4 25
0.3%
4.9%
Q3 25
1.9%
Q2 25
0.8%
Q1 25
8.2%
Q4 24
0.6%
6.5%
Q3 24
2.3%
Q2 24
0.8%
Q1 24
1.0%
Cash Conversion
TLSI
TLSI
WNEB
WNEB
Q4 25
3.50×
Q3 25
1.76×
Q2 25
1.49×
Q1 25
-0.54×
Q4 24
3.70×
Q3 24
1.57×
Q2 24
0.56×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons